Deepika Padukone’s D2C startup 82°E bags USD 7.5 Mn funding


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
Deepika Padukone-led self-care brand 82°E raises USD 7.5 million in funding. ‘Ashwagandha Bounce' moisturiser and 'Patchouli Glow' sunscreen drops are the inaugural skincare products.

Deepika Padukone’s D2C startup 82°E bags USD 7.5 Mn funding

82°E raised USD7.5 Mn in seed funding from DSG Consumer Partners and IDEO Ventures, along with multiple ultra-high net worth individuals (UHNI) and Padukone’s family office. The fund will be utilized to build its team, scale up R&D and launch new products. 82°E has launched two products so far and plans to launch more products in the future.

The D2C personal care startup was founded in 2021 by Bollywood superstar Deepika Padukone and Jigar Shah. It has an R&D lab in Bengaluru to formulate products in-house and the brand employs around 35 people. In November 2022, the brand introduced its inaugural skincare category 'Ashwagandha Bounce' moisturiser and 'Patchouli Glow' sunscreen drops, as the debut products.

In a statement, Padukone said, “Jigar and I envisioned this brand as an extension of my personal as well as professional journey. We set out to launch products which are high-quality, high-performing and an authentic reflection of my beliefs and practices.” 

She added that “With our launch category of skincare products, we have rigorously sourced, carefully crafted and clinically tested our products to achieve lasting results. I am honoured to have investors of global repute join us in our vision to establish 82°E as a modern self-care brand born in India for the world”.

Shah said that celebrity brands are still in their infancy in India, even though the concept has been there for several decades. He said that while India’s personal care space is very competitive, most of the products in it are for the masses.

The brand achieved its month-one target in five-and-a-half days, shipping to 30 countries in the process. According to the co-founder, 82°E is set to achieve INR 100 Cr in annual revenue rate in the next six to eight months.

(Edited by Rajeev Pillai)

 

Tags : #fundingalert #82east #Deepikapadukone #personalcare #skincare #Ashwagandhabounce #Patchouliglow #medicircle #smitakumar

About the Author


Rajeev Pillai

Rajeev Pillai has accumulated extensive experience in the Electronics and Telecom Service Industry with global companies in the Middle East. Being a continuous learner with a lifelong passion for writing, Rajeev writes on topics such as Healthcare, Finance, Travel and Technology.

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026